Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Myosin Light Chain Kinase (MLCK) <strong>Inhibitor</strong>s<br />
Myosin light chain kinase (MLCK), a Ca 2+ -calmodulin<br />
dependent multi-functional enzyme, plays a critical<br />
role in the regulation of smooth muscle contraction and<br />
cellular migration. It regulates the contractile interaction<br />
between actin microfilaments and conventional smooth<br />
muscle and non-muscle myosin II. MLCK is composed of<br />
an N-terminal actin-binding domain, a central kinase<br />
domain, and a C-terminal myosin-binding domain. The<br />
kinase domain activates the interaction of smooth-muscle<br />
myosin with actin by phosphorylating the myosin light<br />
chain. MLCK phosphorylates a specific site on the Nterminus<br />
of the regulatory light chain of myosin II. This<br />
phosphorylation is responsible for coupling increased Ca 2+<br />
concentration with smooth muscle contraction.<br />
In the presence of Ca 2+ , the C-terminal domain of<br />
calmodulin binds to the N-terminus of the calmodulinbinding<br />
sequence of MLCK followed by the binding<br />
Myosin Light Chain Kinase (MLCK) <strong>Inhibitor</strong>s<br />
Calbiochem • <strong>Inhibitor</strong> SourceBook<br />
Phosphorylation/Dephosphorylation<br />
of the N-terminal domain to the C-terminus of the<br />
calmodulin-binding sequence. MLCK is reported to<br />
bind the actin filament in a manner that also allows the<br />
simultaneous binding of the other major thin filament<br />
components; calponin, tropomyosin, etc. The binding site<br />
is suggested to be on the outside of sub-domain 1. There<br />
is approximately one MLCK molecule for every 100 actin<br />
molecules in smooth muscle and each MLCK contains at<br />
least three of the DFRXXL motifs allowing each molecule<br />
to bind three actins (K d = 4 mM).<br />
References:<br />
Kamm, K.E., and Stull, J.T. 200 . J. Biol. Chem. 276, 4527.<br />
Hatch, V., et al. 200 . J. Cell Biol. 154, 6 .<br />
Smith, L., and Stull, J.T. 2000. FEBS let. 480, 298.<br />
Le, L-H., et al. 999. Proc. Natl. Acad. Sci. USA 96, 6666.<br />
Sellers, J.R., and Pato, M.D. 984. J.Biol.Chem. 259, 7740.<br />
Product Cat. No. Comments Size Price<br />
A3, Hydrochloride 100122 [N-(2-Aminoethyl)-5-chloronaphthalene-1-sulfonamide, HCl]<br />
A shorter alkyl chain derivative of W-7 (Cat. No. 68 629) that inhibits MLCK<br />
(K i = 7.4 mM), CK I (K i = 80 mM), CK II (K i = 5. mM), PKA (K i = 4.3 mM), PKC (K i = 47 mM),<br />
and PKG (K i = 3.8 mM).<br />
Gö 7874, Hydrochloride 365252 A potent and selective inhibitor of protein kinase C (IC 50 = 4 nM for rat brain PKC).<br />
Inhibits protein kinase A (IC 50 = 5 0 nM), protein kinase G (IC 50 = 4.8 mM), and myosin<br />
light chain kinase (IC 50 = 20 nM) at much higher concentrations.<br />
K-252a, Nocardiopsis<br />
sp.<br />
InSolution K-252a,<br />
Nocardiopsis sp.<br />
K-252b, Nocardiopsis<br />
sp.<br />
420298 A cell-permeable inhibitor of MLCK (K i = 7 nM), CaM kinase II (K i = .8 nM), PKC<br />
(K i = 25 nM), and PKG (K i = 20 nM). Also acts as a potent inhibitor (IC 50 = 3 nM) of the<br />
protein tyrosine kinase activity of the NGF receptor gp 40 trk .<br />
0 mg $90<br />
500 mg $ 00<br />
00 mg $ 33<br />
420297 A mM ( 00 mg/2 4 ml) solution of K-252a (Cat. No. 420298) in anhydrous DMSO. 00 mg $ 28<br />
420319 A non-selective inhibitor of MLCK (K i = 47 nM), PKA (K i = 90 nM), PKC (K i = 20 nM),<br />
and PKG (K i = 00 nM).<br />
ML-7, Hydrochloride 475880 [1-(5-Iodonaphthalene-1-sulfonyl)homopiperazine, HCl]<br />
A cell-permeable, potent and selective inhibitor of MLCK (K i = 300 nM).<br />
Inhibits PKA (K i = 2 mM) and PKC (K i = 42 mM) at much higher concentrations.<br />
ML-9, Hydrochloride 475882 [1-(5-Chloronaphthalene-1-sulfonyl)homopiperazine, HCl]<br />
A cell-permeable inhibitor of MLCK (K i = 3.8 mM), PKA (K i = 32 mM), and<br />
PKC (K i = 54 mM).<br />
Myosin Light Chain<br />
Kinase <strong>Inhibitor</strong> Peptide<br />
8<br />
475981 (H-RKKYKYRRK-NH 2 ; MLCK <strong>Inhibitor</strong> Peptide 18)<br />
A highly basic nonapeptide that acts as a selective inhibitor of MLCK (IC 50 = 50 nM).<br />
Does not block calmodulin (CaM) or inhibit the activities of CaM Kinase II or PKA.<br />
Piceatannol 527948 (trans-3,3´,4,5´-Tetrahydroxystilbene)<br />
A plant metabolite that preferentially inhibits the activity of p72 Syk (IC 50 ~ 0 mM).<br />
Also acts as an inhibitor of rat liver PKA catalytic subunit (IC 50 = 3 mM), PKC<br />
(IC 50 = 8 mM), and MLCK (IC 50 = 2 mM).<br />
Staurosporine,<br />
Streptomyces sp.<br />
More online... www.calbiochem.com/inhibitors/MLCK<br />
569397 A potent, cell-permeable broad-spectrum inhibitor of protein kinases. Inhibits MLCK<br />
(IC 50 = .3 nM), CaM kinase (IC 50 = 20 nM), PKA (IC 50 = 7 nM), PKC (IC 50 = 700 pM),<br />
and PKG (IC 50 = 8.5 nM).<br />
50 mg<br />
00 mg<br />
$76<br />
$ 33<br />
mg $99<br />
mg $99<br />
5 mg $ 6<br />
00 mg<br />
250 mg<br />
mg $4<br />
$ 43<br />
$302<br />
Technical Support<br />
Phone 800 628 8470<br />
E-mail calbiochem@emdbiosciences.com<br />
29